(1,2-dimethyl-1H-indol-3-yl)(4-methoxyphenyl)methanone | 1352799-85-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (1,2-dimethyl-1H-indol-3-yl)(4-methoxyphenyl)methanone
• 英文别名: (1,2-dimethylindol-3-yl)-(4-methoxyphenyl)methanone
• CAS: 1352799-85-9
• 化学式: C₁₈H₁₇NO₂
• 分子量: 279.338
• InChiKey: XGQGTQNVXJPEJU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  31.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (1,2-dimethyl-1H-indol-3-yl)(4-methoxyphenyl)methanone 在 乙硫醇钠 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 以84%的产率得到(1,2-dimethyl-1H-indol-3-yl)(4-hydroxyphenyl)methanone
  参考文献：
  名称：

  [EN] DEVELOPING POTENT URATE TRANSPORTER INHIBITORS: COMPOUNDS DESIGNED FOR THEIR URICOSURIC ACTION
  [FR] DÉVELOPPEMENT DE PUISSANTS INHIBITEURS DES TRANSPORTEURS D'URATE : COMPOSÉS CONÇUS POUR LEUR ACTION URICOSURIQUE

  摘要：

  公开号：

  WO2012048058A3
• 作为产物：
  描述：

  在 氧气 、 caesium carbonate 作用下， 以 甲苯 为溶剂， 以90%的产率得到(1,2-dimethyl-1H-indol-3-yl)(4-methoxyphenyl)methanone
  参考文献：
  名称：

  通过N-磺酰基酰胺中CC双键的氧化裂解合成二芳基酮

  摘要：

  一个C-C双键的氧化裂解从光化学开发[2 + 2]的二芳基-环的Ñ -tosyl烯酰胺，芳基杂芳基Ñ -tosyl烯酰胺，和Ñ -tosyl环状烯酰胺与单线态分子氧，接着是Cs 2 CO 3介导的开环反应在空气和日光下，不使用光敏剂，可以产生对称和不对称的二芳基，杂二芳基和环状酮，收率高至优异。此外，从铜炔催化的[3 + 2]-环加成，Rh催化的烷氧基化，光氧合和开环反应中合成了对称和不对称的酮，证明了1-炔烃中C-C三键的氧化裂解。一锅。因为带有给电子基团的对称和不对称的二芳基和/或杂二芳基酮的合成不容易，所以本方法是值得注意的。

  DOI：

  10.1021/acs.joc.7b03068

文献信息

• Palladium catalyzed carbonylative generation of potent, pyridine-based acylating electrophiles for the functionalization of arenes to ketones
  作者：Yi Liu、Angela M. Kaiser、Bruce A. Arndtsen

  DOI：10.1039/d0sc03129a

  日期：——

  ultimate elimination of a new class of potent Friedel–Crafts acylating agent: N-acyl pyridinium salts. The latter can be exploited to modulate reactivity and selectivity in carbonylative arene functionalization chemistry, and allow the efficient synthesis of ketones with a diverse array of (hetero)arenes.

  我们在这里描述了钯催化路线的设计，该路线通过（杂）芳烃与芳基或乙烯基三氟甲磺酸酯的羰基化偶联生成芳基酮。在这种情况下，在钯上使用大咬角的Xantphos配体提供了一条独特的途径，可以平衡相对较强的C（sp 2）-OTf键的活化与最终消除新型强力Friedel-Crafts酰化剂：N-酰基吡啶鎓盐。可以利用后者来调节羰基芳烃官能化化学中的反应性和选择性，并允许有效地合成具有多种（杂）芳烃的酮。
• 3-Acylindoles Synthesis: Ruthenium-Catalyzed Carbonylative Coupling of Indoles and Aryl Iodides
  作者：Zechao Wang、Zhiping Yin、Xiao-Feng Wu

  DOI：10.1021/acs.orglett.7b02320

  日期：2017.9.1

  A novel and convenient procedure for the synthesis of 3-acylindoles from simple indoles and aryl iodides has been established. Through ruthenium-catalyzed carbonylative C–H functionalization of indoles, with Mo(CO)6 as the solid CO source, the desired indol-3-yl aryl ketones were isolated in moderate to good yields. Not only N-alkylindoles but also N-H indoles can be applied here.

  已经建立了从简单的吲哚和碘代芳烃合成3-酰基吲哚的新颖且方便的方法。通过钌催化的吲哚的羰基化CH功能化，以Mo（CO）6作为固体CO源，可以中等至良好的收率分离出所需的吲哚-3-基芳基酮。不仅Ñ -alkylindoles而且N- ħ吲哚可以在这里应用。
• DEVELOPING POTENT URATE TRANSPORTER INHIBITORS: COMPOUNDS DESIGNED FOR THEIR URICOSURIC ACTION
  申请人：Wempe Michael F.

  公开号：US20130225673A1

  公开（公告）日：2013-08-29

  A compound represented by the general Formula I: a pharmaceutically acceptable salt or ester thereof, a solvate thereof, a chelate thereof, a non-covalent complex thereof, a pro-drug thereof, a deuterated radio-labeled analog thereof, and mixtures of any of the foregoing, wherein: A-K are individually selected from carbon or nitrogen; X═—O, —NR 1 , or —S; R 1-11 are individually selected from the group consisting of —H, C 1 -C 6 alkyl, C 6 -C 14 aryl, substituted C 6 -C 14 aryl, C 1 -C 14 -alkoxy, halogen, hydroxyl, carboxy, cyano, C 1 -C 6 -alkanoyloxy, C 1 -C 6 -alkylthio, C 1 -C 6 -alkylsulfonyl, trifluoromethyl, hydroxy, C 2 -C 6 -alkoxycarbonyl, C 2 -C 6 -alkanoylamino, —O—R 12 , S—R 12 , —SO 2 —R 12 , —NHSO 2 R 12 and —NHCO 2 R 12 , wherein R 12 is phenyl, naphthyl, or phenyl or naphthly substituted with one to three groups selected from C 1 -C 6 -alkyl, C 6 -C 10 aryl, C 1 -C 6 -alkoxy and halogen, and C 4 -C 20 hydroxyheteroaryl wherein the heteroatoms are selected from the group consisting of sulfur, nitrogen, and oxygen.

  一种由通式I表示的化合物：其中，该化合物为药学上可接受的盐或酯、溶剂化物、螯合物、非共价复合物、前药、氘标记的放射性类似物或任何上述物质的混合物，其中：A-K分别选择自碳或氮；X═—O、—NR1或—S；R1-11分别选择自—H、C1-C6烷基、C6-C14芳基、取代的C6-C14芳基、C1-C14烷氧基、卤素、羟基、羧基、氰基、C1-C6-烷酰氧基、C1-C6-烷基硫基、C1-C6-烷基磺酰基、三氟甲基、羟基、C2-C6-烷氧羰基、C2-C6-烷酰胺基、—O—R12、S—R12、—SO2—R12、—NHSO2R12和—NHCO2R12，其中R12为苯基、萘基或苯基或萘基，且其上选择了一到三个来自C1-C6烷基、C6-C10芳基、C1-C6烷氧基和卤素的基团以及C4-C20羟基杂芳基，其中杂原子选择自硫、氮和氧。
• Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
  申请人：Wempe Michael F.

  公开号：US10005750B2

  公开（公告）日：2018-06-26

  A compound represented by the general Formula I: a pharmaceutically acceptable salt or ester thereof, a solvate thereof, a chelate thereof, a non-covalent complex thereof, a pro-drug thereof, a deuterated radio-labeled analog thereof, and mixtures of any of the foregoing, wherein: A-K are individually selected from carbon or nitrogen; X═—O, —NR1, or —S; R1-11 are individually selected from the group consisting of —H, C1-C6 alkyl, C6-C14 aryl, substituted C6-C14 aryl, C1-C14-alkoxy, halogen, hydroxyl, carboxy, cyano, C1-C6-alkanoyloxy, C1-C6-alkylthio, C1-C6-alkylsulfonyl, trifluoromethyl, hydroxy, C2-C6-alkoxycarbonyl, C2-C6-alkanoylamino, —O—R12, S—R12, —SO2—R12, —NHSO2R12 and —NHCO2R12, wherein R12 is phenyl, naphthyl, or phenyl or naphthly substituted with one to three groups selected from C1-C6-alkyl, C6-C10 aryl, C1-C6-alkoxy and halogen, and C4-C20 hydroxyheteroaryl wherein the heteroatoms are selected from the group consisting of sulfur, nitrogen, and oxygen.

  通式 I 所代表的化合物： 其药学上可接受的盐或酯、其溶液、其螯合物、其非共价络合物、其原药、其氚化放射性标记类似物，以及上述任何物质的混合物，其中：A-K分别选自碳或氮； X═-O、-NR1 或 -S；R1-11各自选自由-H、C1-C6-烷基、C6-C14-芳基、取代的C6-C14-芳基、C1-C14-烷氧基、卤素、羟基、羧基、氰基、C1-C6-烷酰氧基、C1-C6-烷硫基、C1-C6-烷磺酰基、三氟甲基、羟基、C2-C6-烷氧羰基、C2-C6-烷酰氨基、-O-R12、S-R12、-SO2-R12、-NHSO2R12 和 -NHCO2R12，其中 R12 是苯基、萘基或被一至三个选自 C1-C6-烷基、C6-C10 芳基、C1-C6-烷氧基和卤素的基团取代的苯基或萘基，以及 C4-C20 羟基杂芳基，其中杂原子选自由硫、氮和氧组成的组。
• Human Uric Acid Transporter 1 (hURAT1): An Inhibitor Structure–Activity Relationship (SAR) Study
  作者：M. F. Wempe、B. Quade、P. Jutabha、T. Iwen、M. Frick、P. J. Rice、S. Wakui、H. Endou

  DOI：10.1080/15257770.2011.594031

  日期：2011.12

  The current study describes the chemical synthesis of a series of (2-ethylbenzofuran-3-yl)(substituted-phenyl) methanone compounds and their subsequent in vitro testing via oocytes expressing hURAT1. The experimental data support the notion that a potent hURAT1 inhibitor requires an anion (i.e., a formal negative charge) to interact with the positively charged hURAT1 binding pocket. An anion appears to be a primary requirement in order to be a hURAT1 substrate (i.e., urate) or inhibitor. We discuss the inhibitor structure-activity relationship and how electronically donating or withdrawing groups attached to the B-ring can decrease or increase inhibitory potency, respectively.